← Evidence library

BIB_441

Omega-3 (marine n-3 PUFA / fish oil) & melanoma — the CALIBRATED "fine for cardiovascular/competing-risk, NOT a melanoma measure" supplement entry. Fills a real gap: omega-3 appears corpus-wide only as a generic peri-op-bleeding stop-list item (TASK13a), never as a melanoma-specific supplement-discipline assessment — and the patient is ACTIVELY TAKING Omega-3 ~500 mg/day (current stack, TASK13a §0.2). Sibling calibration to melatonin (BIB436): mechanistically favourable/neutral and NOT pro-oncogenic (unlike high-dose antioxidants BIB126 or telomerase activators BIB414), but melanoma-speci…

Evidence grade

C

Tier

2–3 (comprehensive supplement review + supportin

Cited by tasks

10, 13a, 22a, 26

Identifiers

PMC12524211

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_441/findings.md (research corpus). This page is a short context summary — not individualised medical advice.